Institutional investors purchased a net $10.9 million shares of MNKD during the quarter ended September 2013. This may signal that the smart money is gaining interest in this company as the 21.84% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
THE VANGUARD GROUP, INC. Bought 3.5 Million shares of Mannkind Corp
GREYWOLF CAPITAL MANAGEMENT LP Bought 1.4 Million shares of Mannkind Corp
HIGHBRIDGE CAPITAL MANAGEMENT LL... Bought 1.4 Million shares of Mannkind Corp